María Teresa
Paíno Gómez
Profesora Permanente Laboral
Andrea
Díaz Tejedor
Forscherin in der Zeit 2017-2023
Publikationen, an denen er mitarbeitet Andrea Díaz Tejedor (7)
2024
-
Tinostamustine (EDO-S101), an Alkylating Deacetylase Inhibitor, Enhances the Efficacy of Daratumumab in Multiple Myeloma by Upregulation of CD38 and NKG2D Ligands
International Journal of Molecular Sciences, Vol. 25, Núm. 9
2021
-
Immune system alterations in multiple myeloma: Molecular mechanisms and therapeutic strategies to reverse immunosuppression
Cancers, Vol. 13, Núm. 6, pp. 1-26
-
Stroma-Mediated Resistance to S63845 and Venetoclax through MCL-1 and BCL-2 Expression Changes Induced by miR-193b-3p and miR-21-5p Dysregulation in Multiple Myeloma
Cells, Vol. 10, Núm. 3
2020
-
Preclinical evaluation of the simultaneous inhibition of MCL-1 and BCL-2 with the combination of S63845 and venetoclax in multiple myeloma
Haematologica
-
Protein translation inhibition is involved in the activity of the pan-pim kinase inhibitor pim447 in combination with pomalidomide-dexamethasone in multiple myeloma
Cancers, Vol. 12, Núm. 10, pp. 1-20
2019
-
Biological Background of Resistance to Current Standards of Care in Multiple Myeloma
Cells, Vol. 8, Núm. 11
2017
-
The kinesin spindle protein inhibitor filanesib enhances the activity of pomalidomide and dexamethasone in multiple myeloma
Haematologica, Vol. 102, Núm. 12, pp. 2113-2124